Statement: hormone receptor negative breast cancer patients who have undergone two rounds of previous treatments can participate in the primary clinical trial
Primary_evidence: Inclusion Criteria:   Confirmed hormone receptor positive advanced breast cancer, postmenopausal women Exclusion Criteria:   Previous treatment for advanced breast cancer (previous treatment for early breast cancer is allowed).